Дисертації з теми "Mouse model and breast cancer"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 дисертацій для дослідження на тему "Mouse model and breast cancer".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.
Herschkowitz, Jason I. Perou Charles M. "Breast cancer subtypes, mouse models, and microarrays." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2007. http://dc.lib.unc.edu/u?/etd,1728.
Повний текст джерелаTitle from electronic title page (viewed Sep. 16, 2008). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Curriculum of Genetics and Molecular Biology." Discipline: Genetics and Molecular Biology; Department/School: Medicine.
Lesurf, Robert. "Molecular pathway analysis of mouse models for breast cancer." Thesis, McGill University, 2009. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=32499.
Повний текст джерелаLe cancer du sein est connue pour être une maladie très hétérogène, composé d'un nombre de différents sous-types avec différents niveaux de l'agressivité et distinctes, mais indéfini, profils moléculaires. Ici, nous avons analysé plusieurs nouveaux modèles de souris pour le cancer du sein, dans le cadre des sous-types, et nous avons trouver des parallèles à un certain nombre de niveaux pertinents biologiques. En outre, nous avons développé une méthodologie statistique pour aider à élucider les différents composants moléculaires qui sont à jouer dans un groupe de tumours de sein d'humains ou mammaires murins. Nos résultats indiquent que, même si aucun modèle de souris capte tous les aspects de la maladie chez l'homme, chacun contiennent des composants qui sont partagées par un sous-ensemble de tumeurs mammaires humaines. En outre, notre outil statistique offre de nombreux avantages par rapport aux précédentes méthodes, pour aider à révéler les voies moléculaires qui composent la biologie des tumeurs.
Simpson, Peter Thomas. "Differential gene expression analysis in a transgenic mouse model of metastatic breast cancer." Thesis, University of Liverpool, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.343681.
Повний текст джерелаAlhazmi, Aiman. "Role of Nucleosome Remodeling Factor (NURF) in Tumorigenesis Using a Breast Cancer Mouse Model." VCU Scholars Compass, 2012. http://scholarscompass.vcu.edu/etd/379.
Повний текст джерелаRobey, Ian, and Natasha Martin. "Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer." BioMed Central, 2011. http://hdl.handle.net/10150/610344.
Повний текст джерелаPochampalli, Mamata Rani. "Characterization of Effects of Muc1 Expression on Epidermal Growth Factor Receptor Signaling in Breast Cancer." Diss., The University of Arizona, 2006. http://hdl.handle.net/10150/194355.
Повний текст джерелаKe, Jia-Yu. "Bioactivity of Naringenin in Metabolic Dysregulation and Obesity-Associated Breast Cancer in a Mouse Model of Postmenopause." The Ohio State University, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=osu1437479457.
Повний текст джерелаHeilmann, Katharina [Verfasser], and Karin [Akademischer Betreuer] Müller-Decker. "Epigenetic characterization of the C3(1) SV40T mouse model of human breast cancer / Katharina Heilmann ; Betreuer: Karin Müller-Decker." Heidelberg : Universitätsbibliothek Heidelberg, 2017. http://d-nb.info/1178008134/34.
Повний текст джерелаBalderstone, Lucy Anne. "Use of fluorescent imaging to monitor drug responses in mouse models of tumourigenesis." Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/17859.
Повний текст джерелаMilliken, Erin L. "USE OF A TRANSGENIC MOUSE MODEL OF OVARIAN HYPERSTIUMLUATION TO IDENTIFY THERAPEUTIC TARGETS AND MECHANISMS IN HORMONE-INDUCED MAMMARY CANCER." Case Western Reserve University School of Graduate Studies / OhioLINK, 2005. http://rave.ohiolink.edu/etdc/view?acc_num=case1121273034.
Повний текст джерелаMitterer, Chantal. "The role of inflammation induced by radiation or lipopolysaccharides in the metastatic process in a mouse model of breast cancer." Mémoire, Université de Sherbrooke, 2012. http://hdl.handle.net/11143/6343.
Повний текст джерелаKnostman, Katherine A. B. "Sodium/iodide symporter regulation by oncogenes in the mammary gland and thyroid gland using mouse models." The Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc_num=osu1181659993.
Повний текст джерелаAlkhatib, Suehyb. "Characterizing the role of Nucleosome Remodeling Factor (NURF) in tumorigenesis and metastatic progression using mouse models of breast cancer." VCU Scholars Compass, 2012. http://scholarscompass.vcu.edu/etd/376.
Повний текст джерелаOrdonez, Liliana. "Investigation of response and resistance to PARP inhibition in mouse models of human BRCA2-mutant breast cancer." Thesis, Cardiff University, 2014. http://orca.cf.ac.uk/68611/.
Повний текст джерелаBolin, Celeste, Caleb Sutherland, Ken Tawara, Jim Moselhy, and Cheryl Jorcyk. "Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis." BioMed Central, 2012. http://hdl.handle.net/10150/610032.
Повний текст джерелаWalker, Kelcey Manae Becker. "Inhibitory actions of Ah receptor agonists and indole-containing compounds in breast cancer cell lines and mouse models." Texas A&M University, 2002. http://hdl.handle.net/1969.1/2433.
Повний текст джерелаCollier, Jenna Lynn. "Investigation into the role of eosinophils in pulmonary metastasis and primary tumours in mouse models of breast cancer." Thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62442.
Повний текст джерелаMedicine, Faculty of
Pathology and Laboratory Medicine, Department of
Graduate
Creedon, Helen. "Use of genetically engineered mouse models in preclinical drug development." Thesis, University of Edinburgh, 2015. http://hdl.handle.net/1842/15911.
Повний текст джерелаChahrour, Ghada. "Estrogen-related receptor [alpha] (ERR[alpha]), estrogen receptor [alpha] (ERA[alpha]) and erbB-E (Neu) crosstalk in a mouse model of human breast cancer." Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=80237.
Повний текст джерелаRossdeutscher, Lionel Philip David. "The role of tumoral 1,25 dihydroxyvitamin D3 in inhibition of tumor growth and progression in the PyVMT MMTV#634 transgenic breast cancer model /." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112354.
Повний текст джерелаAhmad, Fahmida. "Modelling heterogeneity of triple-negative breast cancer in mice to uncover and target signaling essentiality." Thesis, Aix-Marseille, 2020. http://www.theses.fr/2020AIXM0225.
Повний текст джерелаTriple-negative breast cancer (TNBC) is a highly aggressive, heterogeneous breast cancer subtype, and has currently no effective treatment. The aim of my PhD project was to understand the mechanisms triggering TNBC and to develop new therapeutic approaches.In our lab, we have generated a unique mouse model (MMTV-R26Met mice) in which a subtle increase in the expression levels of the wild-type MET receptor tyrosine kinase leads to spontaneous, exclusive TNBC formation. This model recapitulates formation of lung metastasis, resistance to conventional chemotherapeutic agents and to a set of combined targeted molecular therapies.Proteomic profiling of MMTV-R26Met tumors and machine learning approach showed that the MMTV-R26Met model largely recapitulates TNBC heterogeneity observed in TNBC patients. We identified two new drug combinations highly deleterious for the MMTV-R26Met tumor-derived cell lines, and a panel of human TNBC cells. The first drug combination targets the anti-apoptotic factor BCL-XL and CDK1/2 (cell cycle regulators). The second drug combination, validated by in vivo studies, is based on a combinatorial targeting of BCL-XL and of WEE1 (cell cycle and epigenetic regulator). Mechanistically, we show that combined inhibition of WEE1 and BCL-XL leads to DNA damage, premature entry into mitosis, resulting in mitotic catastrophe and apoptosis.Our findings may be highly relevant for their potential translation to the clinic, also in view of promising studies of monotherapy with BCL-XL and WEE1 inhibitors in phase II clinical trials
Nanduri, Siva Lahiri Kanth [Verfasser], Ralph [Akademischer Betreuer] Witzgal, Christoph [Akademischer Betreuer] Klein, and Stephan [Akademischer Betreuer] Schneuwly. "Isolation and in vitro expansion of disseminated cancer cells from bone marrow of a transgenic mouse model of breast cancer / Siva Lahiri Kanth Nanduri. Betreuer: Ralph Witzgal ; Christoph Klein ; Stephan Schneuwly." Regensburg : Universitätsbibliothek Regensburg, 2014. http://d-nb.info/1068055642/34.
Повний текст джерелаFOY, KEVIN CHU. "COMBINATION IMMUNOTHERAPY WITH HER-2/NEU AND VEGF PEPTIDE MIMICS IN BOTH TRANSGENIC AND TRANSPLANTABLE MOUSE MODELS OF HUMAN BREAST CANCER." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1299532419.
Повний текст джерелаPérez, lanzón María. "Modeling Hormone Receptor Positive Breast Cancer in Immunocompetent Mice Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression Organoids for Modeling Genetic Diseases. In: International Review of Cell and Molecular Biology A preclinical mouse model of osteosarcoma to define the extracellular vesicle-mediated communication between tumor and mesenchymal stem cells Failure of immunosurveillance accelerates aging The metabolomic signature of extreme longevity: Naked mole rats versus mice Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity Laminin-binding integrins are essential for the maintenance of functional mammary secretory epithelium in lactation Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer." Thesis, université Paris-Saclay, 2021. http://www.theses.fr/2021UPASL019.
Повний текст джерелаProgress in breast cancer research relies on the availability of suitable cell lines that can be implanted in immunocompetent laboratory mice. The best explored mouse strain, C57Bl/6, is also the only one for which multiple genetic variants are available. Driven by the fact that no hormone receptor-positive C57Bl/6-derived mammary carcinoma cell lines are available, we decided to establish such cell lines. Breast cancers were induced in female C57BL/6 mice using a synthetic progesterone analogue combined with a DNA damaging agent. Cell lines were established from these tumors and selected for dual (estrogen + progesterone) receptor positivity, as well as transplantability into C57BL/6 females. One cell line, which we called MD5,fulfilled these criteria and allowed for the establishment of poorly differentiated, highly proliferative, immune cold tumors. Such tumors reduced their growth (though did not regress) upon treatment with estrogen receptor antagonists, as well as with anthracyline-based chemotherapy. However, the latter effect was not influenced by T cell depletion and MD tumors failed to respond to PD-1 blockade, suggesting that they are immunologically cold. In conclusion, C57BL/6-derived MD5 cells constitute a model of poor prognosis hormone receptor-positive breast cancer
Vallerand, David. "Etude du stroma de tumeurs mammaires humaines xénogreffées et de modèles transgéniques murins." Thesis, Paris 11, 2014. http://www.theses.fr/2014PA11T001.
Повний текст джерелаTumor development is a multi-step process influencing by interactions between tumor cells and surrounding stroma. Breast cancer development involves a high level of communication between mammary epithelial cells, inflammatory cells, myofibroblasts and endothelial cells. So, the tumoral microenvironment appears as a prime target for anti-tumoral treatment. The use of preclinical models is a critical step in development and validation processes of new therapies. Nevertheless, the role of stroma in these models is poorly understood.In order to evaluate stromal cell populations in breast cancer preclinical models, we combined flow cytometry analysis and immunohistochemistry to identify, and then quantify, various stromal populations as hematopoietic cells (lymphocytes, monocytes/macrophages, polymorphonuclear leukocytes) and non-hematopoietic cells (myofibroblasts, endothelial cells). Twenty-one breast cancer patient-derived xenografts as well as 2 transgenic mouse models (MMTV-PyMT and MMTV-ErbB2), and their respective allografts, were studied.Analysis of human and murine tumors showed a strong heterogeneity between tumors regarding infiltrating stroma-cells, with a high proportion of macrophages. A significant amount of polymorphonuclear leukocytes was also detected in PDXs, indicating a local inflammation in these models. The phenotypic analysis of macrophages showed a variable expression of M1 and M2 markers in PDXs. Macrophages infiltrating transgenic mouse tumors, spontaneous or allografted, were mainly M1. Transcriptomic analyses of sorted macrophages, allowed us to validate previous results but also highlighted major differences in the expression of numerous genes implicated in various pathways as tumor growth, invasion and metastasis.Finally, this study highlighted the impact of tumor cells on their surrounding stroma. Indeed, we demonstrate that cancer cells are able to attract a specific panel of stromal cells and activate them in a specific way
Scully, Jaqueline Susan. "Insertion of oncogenes into mouse mammary epithelium." Thesis, University of Cambridge, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315287.
Повний текст джерелаChambers, Julie Anne. "Analysis of the BRCA1 region in human and mouse." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298465.
Повний текст джерелаAbram, Clare L. "Expression of oncogenes in mouse mammary epithelium by transplantation." Thesis, University of Cambridge, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.307957.
Повний текст джерелаWorrall, Lisa Kirsty. "A 3D in vitro breast cancer model." Thesis, University of Nottingham, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.436812.
Повний текст джерелаKishi, Masae. "Strategies of Cancer Immunotherapy : Model of Triple Negative Breast Cancer." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS070.
Повний текст джерелаCancer stem cells (CSCs) are responsible for tumor progression, metastases, and late relapses. They have been identified in many cancers, such as triple negative breast cancer (TNBC) and grade III to IV cancers. They are resistant to chemotherapy and radiotherapy and reside in an immuno-repressive niche.This study aims to evaluate a immunotherapy strategy that selectively targets CSCs in the mouse model 4T1-GFP-Luc mimicking TNBC. The phenotype / genotype of mammosphere was initially characterized. Based on genomic analysis of CSC, we have developed an active immunotherapy associated with immunomodulatory agents. We measured the size of tumors and monitored the appearance of metastases by bioluminescence. We performed an immunological study and genomic tumor analysis. The therapeutic combination causes the recruitment of CD4 + and CD8 + T lymphocytes and B lymphocytes with increased CXCL13, the reduction of T reg cells and suppressive myeloid cells in the tumor. This induction of intra-tumor immune response leads to a decrease in tumor size and metastases.This new active immunotherapy can be used in combination with current treatments for prophylactic and curative measures in a wide variety of cancers
Meaney, Mary Patricia. "The growth of murine breast cancer cells in dystrophic mice." Diss., Virginia Tech, 2011. http://hdl.handle.net/10919/40177.
Повний текст джерелаPh. D.
Jones, Christina Michele. "Applications and challenges in mass spectrometry-based untargeted metabolomics." Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/54830.
Повний текст джерелаBobick, Todd M. "Transtheoretical model and exercise in breast cancer survivors." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape8/PQDD_0020/MQ47009.pdf.
Повний текст джерелаFazeli, Amin. "Construction of a mouse model of colon cancer." Thesis, Massachusetts Institute of Technology, 1997. http://hdl.handle.net/1721.1/43348.
Повний текст джерелаCong, Chunling. "Statistical Analysis and Modeling of Breast Cancer and Lung Cancer." Scholar Commons, 2010. http://scholarcommons.usf.edu/etd/3563.
Повний текст джерелаPatino, Patricia. "Breast cancer: Relationship between acculturation and barriers to breast cancer screening in Southwest Florida Latinas." Scholar Commons, 2006. http://scholarcommons.usf.edu/etd/2656.
Повний текст джерелаŽelvienė, Aušra. "Women beliefs towards breast cancer, breast self-examination and mammography in connection with participation in breast cancer screening." Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2008. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2008~D_20080129_121108-78281.
Повний текст джерелаŠio darbo tikslas buvo įvertinti atvykusių ir neatvykusių tikrintis mamografiškai moterų nuostatų į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą skirtumus. Tikslui pasiekti iškelti tokie uždaviniai: 1. Įvertinti Champion VL sveikatos įsitikinimų modelio klausimyno tinkamumą tirti Lietuvos moterų nuostatoms į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą. 2. Nustatyti moterų suvoktą krūties vėžio grėsmę, apsaugančios nuo krūties vėžio pasekmių elgsenos naudą ir kliūtis šiai veiklai, sveikos gyvensenos motyvaciją. 3. Palyginti atvykusių ir neatvykusių tirtis mamografiškai dėl krūties vėžio moterų nuostatas į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą. 4. Įvertinti dalyvavusių atrankinėje mamografinėje patikroje dėl krūties vėžio moterų kliūtis tirtis mamografiškai. 5. Ištirti papildomos informacijos apie krūties vėžį, mamografinę patikrą įtaką moterų nuostatoms į krūties vėžį, savityrą bei atrankinę mamografinę patikrą ir moterų dalyvavimui atrankinės patikros programoje. Išvados: 1. Patikrintas ir įteisintas VL Champion sveikatos įsitikinimų modelio skalės klausimynas yra tinkamas Lietuvos moterų nuostatoms į krūties vėžį, krūtų savityrą ir atrankinę mamografinę patikrą tirti. Sveikos gyvensenos motyvacijos skalė turi būti padalinta į požiūrio į sveiką gyvenseną ir veiklos sveikatos labui subskales. Kliūčių tirtis mamografiškai teiginys “reguliarus mamografinis ištyrimas verstų mane nerimauti dėl krūties vėžio” išbrauktas... [toliau žr. visą tekstą]
Wang, Ying. "Mouse Models of Menopause and Ovarian Cancer Risks." Scholarly Repository, 2011. http://scholarlyrepository.miami.edu/oa_dissertations/681.
Повний текст джерелаKim, Jong Bin. "Development of a fully "humanized" xenograft model of breast cancer." Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1444826/.
Повний текст джерелаClifford, Adrianne Brown. "Tumor Associated Macrophages in a MaFIA Mouse Model." Diss., CLICK HERE for online access, 2006. http://contentdm.lib.byu.edu/ETD/image/etd1427.pdf.
Повний текст джерелаLawson, Jessica Clair. "Analysis of the anti-cancer activity of novel indigenous algal compounds in breast cancer: towards the development of a model for screening anti-cancer stem cell activity." Thesis, Rhodes University, 2010. http://hdl.handle.net/10962/d1003984.
Повний текст джерелаAntoniou, A. C. "Developing a comprehensive risk model for familial breast and ovarian cancer." Thesis, University of Cambridge, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.596129.
Повний текст джерелаTitova, A. Yu. "Fuzzy Model Thermal Image Analysis for Detection Breast Cancer in Women." Thesis, Sumy State University, 2016. http://essuir.sumdu.edu.ua/handle/123456789/47075.
Повний текст джерелаAn, Wenxin, and 安文欣. "Validation studies of the Gail Model for breast cancer : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206924.
Повний текст джерелаpublished_or_final_version
Public Health
Master
Master of Public Health
Moyo, Buhle. "The screening and characterisation of compounds for modulators of heat shock protein (Hsp90) in a breast cancer cell model." Thesis, Rhodes University, 2013. http://hdl.handle.net/10962/d1004129.
Повний текст джерелаMicrosoft� Word 2010
Adobe Acrobat 9.54 Paper Capture Plug-in
Bagshaw, Rachel Jane. "Expression and inhibition of subclass I receptor tyrosine kinases in a rat mammary model." Thesis, University of Liverpool, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.260352.
Повний текст джерелаYu, Kin-wa Bless. "An exploratory design of a body-mind-spirit model for helping breast cancer patients." Click to view the E-thesis via HKUTO, 2002. http://sunzi.lib.hku.hk/hkuto/record/B31979397.
Повний текст джерелаOuinten, Y. "Models to evaluate schemes for an early detection of breast cancer." Thesis, University of Southampton, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380582.
Повний текст джерелаDevamitta, Perera Muditha V. "Statistical Analysis and Modeling of Ovarian and Breast Cancer." Scholar Commons, 2017. https://scholarcommons.usf.edu/etd/7395.
Повний текст джерелаDraganov, Dobrin Draganov. "MFG-E8 Blockade Enhances Tumor Immunity in a Murine Breast Cancer Model." Thesis, Harvard University, 2012. http://dissertations.umi.com/gsas.harvard:10512.
Повний текст джерела